Details for New Drug Application (NDA): 213814
✉ Email this page to a colleague
The generic ingredient in SILDENAFIL CITRATE is sildenafil citrate. There are twenty drug master file entries for this compound. Sixty-nine suppliers are listed for this compound. Additional details are available on the sildenafil citrate profile page.
Summary for 213814
Tradename: | SILDENAFIL CITRATE |
Applicant: | Somerset Theraps Llc |
Ingredient: | sildenafil citrate |
Patents: | 0 |
Pharmacology for NDA: 213814
Mechanism of Action | Phosphodiesterase 5 Inhibitors |
Medical Subject Heading (MeSH) Categories for 213814
Suppliers and Packaging for NDA: 213814
Tradename | Generic Name | Dosage | NDA | Application Type | Supplier | National Drug Code | Package Code | Package |
---|---|---|---|---|---|---|---|---|
SILDENAFIL CITRATE | sildenafil citrate | FOR SUSPENSION;ORAL | 213814 | ANDA | Virtus Pharmaceuticals, LLC | 69543-419 | 69543-419-72 | 1 BOTTLE in 1 CARTON (69543-419-72) / 112 mL in 1 BOTTLE |
Profile for product number 001
Active Rx/OTC/Discontinued: | RX | Dosage: | FOR SUSPENSION;ORAL | Strength | EQ 10MG BASE/ML | ||||
Approval Date: | Apr 29, 2021 | TE: | AB | RLD: | No |
Complete Access Available with Subscription